# A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma

> **NCT06110650** · NA · UNKNOWN · sponsor: **Fudan University** · enrollment: 29 (estimated)

## Conditions studied

- Soft Tissue Sarcoma Adult

## Interventions

- **DRUG:** Surufatinib

## Key facts

- **NCT ID:** NCT06110650
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-28
- **Primary completion:** 2024-08-15
- **Final completion:** 2025-08-15
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06110650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06110650, "A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT06110650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*